23.07.2013 Views

CMS Manual System - Louisiana Department of Health and Hospitals

CMS Manual System - Louisiana Department of Health and Hospitals

CMS Manual System - Louisiana Department of Health and Hospitals

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Whether the signs, symptoms, or related causes are persistent or clinically<br />

significant enough (e.g., causing functional decline) to warrant the initiation or<br />

continuation <strong>of</strong> medication therapy;<br />

Whether non-pharmacological interventions are considered;<br />

Whether a particular medication is clinically indicated to manage the symptom or<br />

condition; <strong>and</strong><br />

Whether the intended or actual benefit is sufficient to justify the potential risk(s)<br />

or adverse consequences associated with the selected medication, dose, <strong>and</strong><br />

duration.<br />

The content <strong>and</strong> extent <strong>of</strong> the evaluation may vary with the situation <strong>and</strong> may employ<br />

various assessment instruments <strong>and</strong> diagnostic tools. Examples <strong>of</strong> information to be<br />

considered <strong>and</strong> evaluated may include, but are not limited to, the following:<br />

An appropriately detailed evaluation <strong>of</strong> mental, physical, psychosocial, <strong>and</strong><br />

functional status, including comorbid conditions <strong>and</strong> pertinent psychiatric<br />

symptoms <strong>and</strong> diagnoses <strong>and</strong> a description <strong>of</strong> resident complaints, symptoms, <strong>and</strong><br />

signs (including the onset, scope, frequency, intensity, precipitating factors, <strong>and</strong><br />

other important features);<br />

Each resident‘s goals <strong>and</strong> preferences;<br />

Allergies to medications <strong>and</strong> foods <strong>and</strong> potential for medication interactions;<br />

A history <strong>of</strong> prior <strong>and</strong> current medications <strong>and</strong> non-pharmacological interventions<br />

(including therapeutic effectiveness <strong>and</strong> any adverse consequences);<br />

Recognition <strong>of</strong> the need for end-<strong>of</strong>-life or palliative care; <strong>and</strong><br />

The refusal <strong>of</strong> care <strong>and</strong> treatment, including the basis for declining it, <strong>and</strong> the<br />

identification <strong>of</strong> pertinent alternatives.<br />

NOTE: The CAAs, an integral part <strong>of</strong> the comprehensive resident assessment,<br />

help identify some possible categories <strong>of</strong> causes <strong>of</strong> various symptoms<br />

including: behavioral symptoms <strong>of</strong> distress, delirium, <strong>and</strong> changes in<br />

functional status. Refer to 42 CFR 483.20 <strong>and</strong> the MDS <strong>and</strong> CAAs.<br />

Circumstances that warrant evaluation <strong>of</strong> the resident <strong>and</strong> medication(s) may include:<br />

Admission or re-admission;<br />

A clinically significant change in condition/status;<br />

A new, persistent, or recurrent clinically significant symptom or problem;

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!